Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Mycophenolate Mofetil and Valganciclovir in Transplant Recipients
NCT00189150Phase 4Completed
- Sponsor
- University of Michigan
- Start
- Apr 2005
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mycophenolate mofetil, valganciclovir in kidney transplant rejection, heart transplant rejection, cytomegalovirus infection (CMV), sponsored by University of Michigan. Started Apr 2005; status: completed.
02
Drugs
mycophenolate mofetilvalganciclovir
03
Conditions
kidney transplant rejectionheart transplant rejectioncytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT00189150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00189150.